Delivery Order SPE2DR25D3013-SPE2DR26F6U4S
- Not listed
- The Defense Logistics Agency awarded a $4.34K delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Sotyktu 6 mg tablets (30-count packaging) with a completion deadline of December 5, 2025. This non-competitive, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,015.47 to AmerisourceBergen Drug Corp for Sotyktu 6 mg tablets (30-count supply) on December 5, 2025, with completion scheduled for December 29, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for Sotyktu 6 mg tablets (30-count supply) valued at $4,338.49. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Sotyktu 6 mg tablets (30-count units) with a ceiling value of $4,338.49. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 18, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $4.34K delivery order to AmerisourceBergen Drug Corp for the supply of Sotyktu 6mg tablets (30-count packaging) under a competitive, non-set-aside procurement. The order, issued on December 3, 2025, is scheduled for completion by December 31, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates on a firm fixed-price basis, typical of DLA's pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $4,338.49 to AmerisourceBergen Drug Corp for SOTYKTU 6 mg tablets (30-count supply) on October 28, 2025, with completion targeted for November 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a $8,676.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sotyktu 6 mg tablets (30-count units) on November 6, 2025, with performance to be completed by December 1, 2025. The award was made on a non-set-aside basis through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order valued at $4,338.49 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Sotyktu 6 mg tablets (30-count units). The contract, which is non-set-aside and competitively awarded, reflects a firm fixed price arrangement with an ultimate completion date of December 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $4,116.81 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sotyktu 6 mg tablets (30-count units). The contract, designated as a firm fixed price delivery order with no set-aside, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a competitively awarded transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Sotyktu 6 mg tablets (30-count units) with a ceiling value of $4,338.49. This firm fixed price delivery order is scheduled for completion by December 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation and represents a child contract under...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6U4SDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4.3K to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Sotyktu 6 mg tablets (30-count units). This competitive, non-set-aside delivery order carries a firm fixed price structure with a completion date of January 2, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver comprehensive pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This award continues the contractor's ongoing support of federal medical supply requirements through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/9/25 |